Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Davita Healthcare Partners Inc (DVA)

Davita Healthcare Partners Inc (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,185,461
  • Shares Outstanding, K 70,600
  • Annual Sales, $ 13,643 M
  • Annual Income, $ 746,800 K
  • EBIT $ 2,759 M
  • EBITDA $ 3,474 M
  • 60-Month Beta 0.99
  • Price/Sales 0.72
  • Price/Cash Flow 6.41
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 35.78% (-0.80%)
  • Historical Volatility 67.59%
  • IV Percentile 59%
  • IV Rank 37.44%
  • IV High 57.57% on 04/08/25
  • IV Low 22.74% on 02/18/25
  • Expected Move (DTE 8) 6.12 (4.07%)
  • Put/Call Vol Ratio 8.79
  • Today's Volume 2,311
  • Volume Avg (30-Day) 3,341
  • Put/Call OI Ratio 1.10
  • Today's Open Interest 38,511
  • Open Int (30-Day) 27,982
  • Expected Range 144.28 to 156.52

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.41
  • Number of Estimates 2
  • High Estimate 2.50
  • Low Estimate 2.32
  • Prior Year 2.00
  • Growth Rate Est. (year over year) +20.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
101.00 +50.17%
on 01/14/26
151.70 -0.02%
on 02/12/26
+41.57 (+37.76%)
since 01/12/26
3-Month
101.00 +50.17%
on 01/14/26
151.70 -0.02%
on 02/12/26
+28.07 (+22.71%)
since 11/12/25
52-Week
101.00 +50.17%
on 01/14/26
178.38 -14.97%
on 02/13/25
-20.33 (-11.82%)
since 02/12/25

Most Recent Stories

More News
DaVita Stock: Is Wall Street Bullish or Bearish?

Are Wall Street analysts bullish or bearish on DaVita’s stock after its fourth-quarter earnings?

XLV : 156.64 (+0.25%)
$SPX : 6,864.25 (-1.11%)
DVA : 151.82 (+5.23%)
The 5 Most Interesting Analyst Questions From DaVita’s Q4 Earnings Call

The 5 Most Interesting Analyst Questions From DaVita’s Q4 Earnings Call

DVA : 151.82 (+5.23%)
Stocks Tumble on AI Disruption Fears

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.84%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.34%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.55%. March E-mini...

TER : 313.63 (-2.43%)
AMAT : 329.79 (-2.97%)
TRIP : 10.40 (-14.47%)
AVGO : 335.30 (-2.18%)
INTU : 394.40 (-1.32%)
HL : 22.05 (-6.92%)
CDE : 21.82 (-5.46%)
MRK : 120.74 (+1.20%)
EXPE : 223.32 (-4.40%)
FN : 472.29 (+1.45%)
TRI : 85.21 (-4.47%)
ADM : 68.99 (-0.45%)
Why Is DaVita (DVA) Stock Rocketing Higher Today

Why Is DaVita (DVA) Stock Rocketing Higher Today

DVA : 151.82 (+5.23%)
Software Stocks Retreat and Drag the Broader Market Lower

The S&P 500 Index ($SPX ) (SPY ) today is down -0.35%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.94%. March E-mini S&P futures (ESH26...

TER : 313.63 (-2.43%)
INTU : 394.40 (-1.32%)
HL : 22.05 (-6.92%)
CDE : 21.82 (-5.46%)
MRK : 120.74 (+1.20%)
FN : 472.29 (+1.45%)
TRI : 85.21 (-4.47%)
ADM : 68.99 (-0.45%)
$IUXX : 24,805.99 (-1.57%)
PFE : 27.62 (-0.40%)
ZNH26 : 112-225 (+0.38%)
ESH26 : 6,877.75 (-1.19%)
Nasdaq Slips, Gold and Silver Stage Substantial Recovery

The S&P 500 Index ($SPX ) (SPY ) today is down -0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.24%. Stock indexes are mixed today,...

TER : 313.63 (-2.43%)
AMAT : 329.79 (-2.97%)
AVGO : 335.30 (-2.18%)
HL : 22.05 (-6.92%)
CDE : 21.82 (-5.46%)
ADI : 334.19 (-0.83%)
MRK : 120.74 (+1.20%)
FN : 472.29 (+1.45%)
ADM : 68.99 (-0.45%)
TXN : 224.70 (-0.82%)
$IUXX : 24,805.99 (-1.57%)
PFE : 27.62 (-0.40%)
DVA Q4 Deep Dive: Clinical Initiatives and Integrated Care Drive Outlook Amid Margin Compression

DVA Q4 Deep Dive: Clinical Initiatives and Integrated Care Drive Outlook Amid Margin Compression

DVA : 151.82 (+5.23%)
DaVita (NYSE:DVA) Beats Expectations in Strong Q4 CY2025, Stock Soars

DaVita (NYSE:DVA) Beats Expectations in Strong Q4 CY2025, Stock Soars

DVA : 151.82 (+5.23%)
DaVita Inc. 4th Quarter 2025 Results

DENVER , Feb. 2, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2025.

DVA : 151.82 (+5.23%)
Elara Caring Secures New Strategic Investment from Ares and DaVita

Partnership will accelerate Elara’s growth and evolution as home health care leader; expand access to high-acuity care for complex diseases through new offerings

ARES : 133.36 (-2.93%)
DVA : 151.82 (+5.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals...

See More

Key Turning Points

3rd Resistance Point 152.57
2nd Resistance Point 148.88
1st Resistance Point 146.58
Last Price 151.82
1st Support Level 140.59
2nd Support Level 136.90
3rd Support Level 134.60

See More

52-Week High 178.38
Last Price 151.82
Fibonacci 61.8% 148.82
Fibonacci 50% 139.69
Fibonacci 38.2% 130.56
52-Week Low 101.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar